Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Oncopeptides Shareholders Equity (Quarterly): 12.22M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 12.22M |
| June 30, 2023 | 16.31M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 28.24M |
| September 30, 2022 | 34.14M |
| June 30, 2022 | 5.709M |
| March 31, 2022 | 12.90M |
| December 31, 2021 | 23.31M |
| September 30, 2021 | 69.61M |
| June 30, 2021 | 161.55M |
| March 31, 2021 | 39.83M |
| December 31, 2020 | 70.45M |
| September 30, 2020 | 119.51M |
| June 30, 2020 | 82.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.45M |
| December 31, 2019 | 85.29M |
| September 30, 2019 | 101.54M |
| June 30, 2019 | 52.63M |
| March 31, 2019 | 76.92M |
| December 31, 2018 | 29.51M |
| September 30, 2018 | 47.34M |
| June 30, 2018 | 56.50M |
| March 31, 2018 | 78.19M |
| December 31, 2017 | 51.12M |
| September 30, 2017 | 58.78M |
| June 30, 2017 | 63.08M |
| December 31, 2016 | 2.905M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.709M
Minimum
Jun 2022
161.55M
Maximum
Jun 2021
52.13M
Average
36.98M
Median
Shareholders Equity (Quarterly) Benchmarks
| Abliva AB | 6.352M |
| BioInvent International AB | 99.49M |
| Hansa Biopharma AB | -31.73M |
| BioArctic AB | 87.57M |
| Camurus AB | 308.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.02M |
| Total Liabilities (Quarterly) | 14.80M |
| Debt to Equity Ratio | 0.8095 |
| Current Ratio | 6.678 |
| Net Debt Paydown Yield | -2.57% |